Financial Network Wealth Advisors LLC Halozyme Therapeutics, Inc. Transaction History
Financial Network Wealth Advisors LLC
- $134 Billion
- Q2 2024
A detailed history of Financial Network Wealth Advisors LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Financial Network Wealth Advisors LLC holds 28 shares of HALO stock, worth $1,637. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28Holding current value
$1,637% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
514Shares Held
124MCall Options Held
208KPut Options Held
77.1K-
Black Rock Inc. New York, NY17.6MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$753 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$340 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$236 Million4.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$217 Million0.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.14B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...